By Dr. Lei Deng
University of Washington & Fred Hutch
Watch Dr. Lei Deng’s overview of the KEYNOTE-671 and NADIM II trials, with important implications for non small cell lung cancer treatment!
Announcing the 2024 Award Recipients for Humanitarianism, Distinguished Faculty, and Volunteer of the Year …
This week, the Binaytara Foundation (BTF) is proud to announce its 2024 Career Advancement Award…
By Joseph Rosales, MD This study presents the case of a 37-year-old woman diagnosed…
By Dr. Richa Parikh In this talk, Dr. Dan Milner discusses various strategies to…
A Pilot Experience with Rwanda Article by Dr. Brenda Santellano Presenter Dr. Regine Nshimiyimana Maniraho…
Enhancing Innate Immunity for the Prevention and Treatment of Cancer in Low Resource Settings Presenter:…